Research and Development

Showing 15 posts of 9578 posts found.

cancer_cells

ICR track cancer to ‘carbon date’ progression

May 11, 2017 Research and Development Cancer, ICR, bowel cancer, oncology

The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease …
scott_gottlieb

Scott Gottlieb appointed to the FDA’s top role

May 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment

After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
phgfoundation_logo_2016_06_21_01_20_28_pm-695x130

Think tank PHG Foundation urges UK government to deliver “transformational change” in NHS

May 11, 2017 Medical Communications, Research and Development PHG Foundation, general election

Joining the wave of associations and organisations vocalising the needs of the health and life sciences industries in the run-up …
tb_bacteria

Body’s natural defence mechanism against TB discovered

May 11, 2017 Research and Development Francis Crick Institute, TB, tuberculosis

Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …
love4life_world_aids_day_foundation_stockholm_sweden_linda_rehlin

HIV life expectancy boosted 10 years by new drugs

May 11, 2017 Research and Development HIV

The latest research to emerge from authors of the University of Bristol has revealed that those living with HIV can …
pharmafile_2017_cover

The Spring 2017 edition of Pharmafile is available to read online now!

May 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile

The Spring 2017 edition of Pharmafile, our bi-annual market intelligence report for the life sciences industry, is available to read …
rocherooflr

Roche blockbuster immunotherapy Tecentriq outclassed by chemo in latest trial

May 10, 2017 Research and Development, Sales and Marketing Roche, tecentriq

It has been revealed that Roche’s immuno-oncology drug Tecentriq (atezolizumab) has failed to hit its primary endpoint in a follow-up …
astrazeneca_building_white

AZ asthma drug falls short in Phase 3 study

May 10, 2017 Research and Development AstraZeneca, asthma, tralokinumab

AstraZeneca and its global biologics research and development arm MedImmune have announced that asthma treatment tralokinumab has failed to achieve …
sanofi_hq_reception_close

Sanofi joins growing list of companies making pricing commitments

May 10, 2017 Medical Communications, Research and Development Sanofi, pricing, transparency

Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …
epi-pen_1_3

Study reveals EpiPens stay effective years after expiration date

May 10, 2017 Research and Development EpiPen expiration, Mylan, Mylan scandal, epipen

The Annals of Internal Medicine has published a study that indicated that EpiPen injectors retain a medically significant proportion of …
scott_gottlieb

Scott Gottlieb appointed to the FDA’s top role

May 10, 2017 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Scott Gottlieb, Trump

After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
dr_sonia_quaratino

Kymab instates first Chief Medical Officer

May 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …
dna-1903319_960_720

University of Oxford gains access to biomarker profiling technology

May 9, 2017 Manufacturing and Production, Research and Development Nightingale health, University of Oxford

The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …
pills-384846_960_720

£6 million statin study to determine potential therapeutic use in MS

May 9, 2017 Manufacturing and Production, Research and Development multiple sclerosis, statins

A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …
The Gateway to Local Adoption Series

Latest content